ArticleBlood2021

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

Tiziana Vaisitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.